NIH-funded research Fellowship grant

Understanding how genetic changes affect brain function in Neurofibromatosis

Official title: Investigating the Role of Somatic Mutations in Neurofibromatosis Brain

Funded at Boston Children's Hospital · NIH-10992105 · Data updated 2026-11-12

This study is looking at how certain genetic changes that happen after birth might affect memory and attention in people with Neurofibromatosis type 1 (NF), by comparing their brain cells to those of healthy individuals.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionBoston Children's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 1, 2023
Project endJune 30, 2025
Funding year2024
Award (this year)$74,284
NIH project number5F32NS133029-02
Project IDNIH-10992105 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Neurofibromatosis type 1, particularly those experiencing neurological symptoms.

Less likely to help

Patients without a diagnosis of Neurofibromatosis or those who do not exhibit neurological deficits may not benefit from this research.

What this research studies

This research investigates the role of genetic mutations that occur after conception in individuals with Neurofibromatosis type 1 (NF), a condition that can lead to tumors and neurological deficits. By comparing the genetic makeup of brain cells from NF patients to those of healthy individuals, the study aims to uncover whether these mutations contribute to cognitive challenges such as memory and attention issues. The researchers will employ advanced sequencing techniques to analyze the genetic changes in brain cells, providing insights into the mechanisms behind these neurological impairments.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and potential treatments for cognitive deficits associated with Neurofibromatosis.

How similar studies have gone: Previous research has shown promising results in understanding genetic mutations in other conditions, suggesting potential success for this novel approach in Neurofibromatosis.

Where this research is happening

  • Boston Children's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Snellings, Daniel — Boston Children's Hospital
  • Study coordinator: Snellings, Daniel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.